Hostname: page-component-6766d58669-bkrcr Total loading time: 0 Render date: 2026-05-19T09:31:41.946Z Has data issue: false hasContentIssue false

Evaluation of the selected parameters of the fetal diastolic functions in normally grown or macrosomic fetuses of gestational diabetic mothers with poor glycaemic control

Published online by Cambridge University Press:  10 January 2022

Seçil Karaca Kurtulmus*
Affiliation:
Department of Obstetrics and Gyneacology, Faculty of Medicine, Izmir Katip Çelebi University, Izmir, Turkey
Ebru Sahin Gülec
Affiliation:
Department of Obstetrics and Gyneacology, Tepecik Educational and Research Hospital, University of Health Sciences, Izmir, Turkey
Mustafa Sengül
Affiliation:
Department of Obstetrics and Gyneacology, Faculty of Medicine, Izmir Katip Çelebi University, Izmir, Turkey
*
Author for correspondence: S. Karaca Kurtulmus, IKCU Atatürk Egitim ve Arastirma Hastanesi, Basin Sitesi, Karabaglar, Izmir, Turkey. Tel: +90 532 482 87 19; Fax: +90 232 243 15 30. E-mail: secilkurtulmus@yahoo.com
Rights & Permissions [Opens in a new window]

Abstract

Objective:

This study aimed to investigate whether the third trimester fetal cardiac diastolic function measured by selected conventional Doppler indices is affected in appropriate-for-gestational-age or macrosomic fetuses of gestational diabetic mothers with poor glycaemic control.

Methods:

This cross-sectional study included 93 pregnant women divided into two groups. Group 1 included 45 appropriate-for-gestational-age or macrosomic fetuses from gestational diabetic mothers with poor glycaemic control (study group). Group 2 included 48 appropriate-for-gestational-age fetuses from gestational age-matched healthy mothers (control group). Functional fetal cardiac parameters and fetoplacental Doppler parameters were measured. Data were compared between the two groups.

Results:

Maternal characteristics did not differ significantly between the study and the control group. There were no significant differences in the early and late velocity, early/late velocity ratio of both mitral and tricuspid valves, the fetal pulmonary vein pulsatility index, and the ductus venosus pulsatility index between the study and the control group. Moreover, the rate of abnormal Doppler findings in pulmonary vein (pulmonary vein pulsatility index >95th centile), ductus venosus (ductus venosus pulsatility index >95th centile), and peripheral vessels (umbilical artery pulsatility index >95th centile, middle cerebral artery pulsatility index <5th centile, cerebra-placental index >95th centile) were comparable in both groups.

Conclusions:

The third trimester fetal diastolic functions measured by selected conventional Doppler techniques do not seem to be altered in appropriate-for-gestational-age or macrosomic fetuses of gestational diabetic mothers who have poor glycaemic control.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction in any medium, provided the original article is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press
Figure 0

Figure 1. Blood flow through mitral valve. Mitral valve (MV), early diastolic filling (e), late diastolic filling (a).

Figure 1

Figure 2. Blood flow through tricuspid valve. Tricuspid valve (TV), early diastolic filling (e), late diastolic filling (a).

Figure 2

Figure 3. Blood flow through right upper pulmonary vein. Right pulmonary vein (PV), systolic flow (S), diastolic flow (D), atrial contraction (a).

Figure 3

Table 1. Comparison of maternal demographic characteristics between the gestational diabetes mellitus and control groups

Figure 4

Table 2. Comparison of fetoplacental Doppler measurements between the gestational diabetes mellitus and control groups

Figure 5

Table 3. Comparison of fetal diastolic functions between the gestational diabetes mellitus and control groups